Yoo, Byunghee
Ross, Alana
Pantazopoulos, Pamela
Medarova, Zdravka
Funding for this research was provided by:
National Cancer Institute (R01CA16346101A1)
Article History
Received: 21 February 2020
Accepted: 12 January 2021
First Online: 2 February 2021
Competing interests
: Zdravka Medarova is Founder of TransCode Therapeutics, Inc. Pamela Pantazopoulos, Alana Ross and Byunghee Yoo do not have any conflict of interest.